Viewing Study NCT00775502


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-03-01 @ 12:05 PM
Study NCT ID: NCT00775502
Status: TERMINATED
Last Update Posted: 2024-04-25
First Post: 2008-10-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
Sponsor: Kyowa Kirin Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module